뉴로페이스 (NPCE) 주가

뉴로페이스(NPCE)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $14.50 (+2.47%), 시가총액 $0.55B, 52주 최저~최고 $8.25 ~ $19.29.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded

핵심 지표

• 현재가: $14.50 (+2.47%)
• 시가총액: $0.55B
• 52주 최저~최고: $8.25 ~ $19.29
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NASDAQ

뉴로페이스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

뉴로페이스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.75

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 37.76
• 순이익률: -0.22%
• 영업이익률: -0.25%

자주 묻는 질문